Surf Therapeutics Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$6M
- Investors
-
17
Surf Therapeutics General Information
Description
Developer of neuromodulatory technology designed for the treatment of autoimmune disorders. The company's technology offers treatment for chronic inflammatory autoimmune disorders without using drugs by using the body's natural anti-inflammatory pathway to restore immune balance, enabling patients to get healthy, balanced, and free from the constraints of pharmaceutical-dependent treatments.
Contact Information
Website
www.surftherapeutics.comCorporate Office
- 1401 Lavaca Street
- Suite 635
- Austin, TX 78701
- United States
Corporate Office
- 1401 Lavaca Street
- Suite 635
- Austin, TX 78701
- United States
Surf Therapeutics Timeline
Surf Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 17-Mar-2026 | $6M | Completed | Clinical Trials - Phase 2 | ||
| 3. Seed Round | 01-Dec-2025 | Completed | Clinical Trials - Phase 2 | |||
| 2. Accelerator/Incubator | 01-Jul-2023 | Completed | Clinical Trials - Phase 2 | |||
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 2 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Surf Therapeutics Patents
Surf Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4820102-A1 | Systems and methods for ultrasound neuromodulation of desired anatomical targets | Pending | 06-Dec-2023 | ||
| US-12551730-B2 | Systems and methods for ultrasound neuromodulation of desired anatomical targets | Active | 06-Dec-2023 | ||
| US-20250360345-A1 | Systems and methods for ultrasound neuromodulation of desired anatomical targets | Active | 06-Dec-2023 | ||
| US-20260199710-A1 | Systems and methods for ultrasound neuromodulation of desired anatomical targets | Pending | 06-Dec-2023 | ||
| WO-2025122461-A1 | Systems and methods for ultrasound neuromodulation of desired anatomical targets | Inactive | 06-Dec-2023 | A61N7/00 |
Surf Therapeutics Signals
Surf Therapeutics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Capital Factory | Accelerator/Incubator | Minority | ||
| Device of Tomorrow Capital | Venture Capital | Minority | ||
| Elderberry Ventures | Venture Capital | Minority | ||
| Evoce Capital | Growth/Expansion | Minority | ||
| General Inception | Venture Capital | Minority |
Surf Therapeutics FAQs
-
When was Surf Therapeutics founded?
Surf Therapeutics was founded in 2022.
-
Where is Surf Therapeutics headquartered?
Surf Therapeutics is headquartered in Austin, TX.
-
What is the size of Surf Therapeutics?
Surf Therapeutics has 10 total employees.
-
What industry is Surf Therapeutics in?
Surf Therapeutics’s primary industry is Drug Discovery.
-
Is Surf Therapeutics a private or public company?
Surf Therapeutics is a Private company.
-
What is Surf Therapeutics’s current revenue?
The current revenue for Surf Therapeutics is .
-
How much funding has Surf Therapeutics raised over time?
Surf Therapeutics has raised $6M.
-
Who are Surf Therapeutics’s investors?
Capital Factory, Device of Tomorrow Capital, Elderberry Ventures, Evoce Capital, and General Inception are 5 of 17 investors who have invested in Surf Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process